These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1783773)

  • 1. Corticosteroids for the treatment of septic shock.
    Sheagren JN
    Infect Dis Clin North Am; 1991 Dec; 5(4):875-82. PubMed ID: 1783773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of antibiotic-induced endotoxin release in septic shock.
    Lepper PM; Held TK; Schneider EM; Bölke E; Gerlach H; Trautmann M
    Intensive Care Med; 2002 Jul; 28(7):824-33. PubMed ID: 12122518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
    Chatterjee S; Premachandran S; Shukla J; Poduval TB
    J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock.
    Murch O; Collin M; Sepodes B; Foster SJ; Mota-Filipe H; Thiemermann C
    Br J Pharmacol; 2006 Jul; 148(6):769-77. PubMed ID: 16751791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of corticosteroids in septic shock.
    Burry LD; Wax RS
    Ann Pharmacother; 2004 Mar; 38(3):464-72. PubMed ID: 14970369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock.
    Quezado ZM; Natanson C; Banks SM; Alling DW; Koev CA; Danner RL; Elin RJ; Hosseini JM; Parker TS; Levine DM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):604-11. PubMed ID: 7853173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glucocorticoids and infection].
    Frey FJ; Speck RF
    Schweiz Med Wochenschr; 1992 Feb; 122(5):137-46. PubMed ID: 1738819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
    Baudo F; de Cataldo F
    Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic steroids in severe sepsis and septic shock.
    Patel GP; Balk RA
    Am J Respir Crit Care Med; 2012 Jan; 185(2):133-9. PubMed ID: 21680949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids in sepsis and septic shock: has the jury reached a verdict?
    Putterman C
    Isr J Med Sci; 1989 Jun; 25(6):332-8. PubMed ID: 2661496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock.
    de Jong MF; Beishuizen A; Spijkstra JJ; Groeneveld AB
    Crit Care Med; 2007 Aug; 35(8):1896-903. PubMed ID: 17568326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin replacement in patients with sepsis and septic shock.
    Giudici D; Baudo F; Palareti G; Ravizza A; Ridolfi L; D' Angelo A
    Haematologica; 1999 May; 84(5):452-60. PubMed ID: 10329925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications].
    Briegel J
    Wien Klin Wochenschr; 2000 Apr; 112(8):341-52. PubMed ID: 10849939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of corticosteroid treatment in sepsis and septic shock: pro or con.
    Nicholson DP
    Crit Care Clin; 1989 Jan; 5(1):151-5. PubMed ID: 2647222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cortisol in critically ill patients with sepsis--physiological functions and therapeutic implications].
    Briegel J
    Wien Klin Wochenschr; 2002; 114 Suppl 1():9-19. PubMed ID: 15503552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial.
    Dellinger RP; Tomayko JF; Angus DC; Opal S; Cupo MA; McDermott S; Ducher A; Calandra T; Cohen J;
    Crit Care Med; 2009 Nov; 37(11):2929-38. PubMed ID: 19770753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasmapheresis in the treatment of septic shock].
    Busund R
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):776-8. PubMed ID: 15039806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model.
    Villar J; Ribeiro SP; Mullen JB; Kuliszewski M; Post M; Slutsky AS
    Crit Care Med; 1994 Jun; 22(6):914-21. PubMed ID: 8205824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.